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INTRODUCTION:  Primary  gastric  choriocarcinoma  accounts  for 0.08%  of  all gastric  cancers.  It is  a  rapidly
growing,  widely  metastatic  and  -HCG-producing  tumour  of  trophoblastic  cells.
PRESENTATION  OF  CASE:  A  69-year-old  white  man  presented  to  the  hospital  with  symptomatic  anaemia.
An  upper  gastrointestinal  endoscopy  showed  an  ulcer of the  cardia  and  lesser  curvature,  whose  biopsy
specimens  proved  to  be malignant  (carcinoma  cells,  non-speciﬁed).  The  patient  underwent  total  gas-
trectomy  with  D2  lymphadenectomy.  A  histologic  evaluation  revealed  a  choriocarcinoma  admixed  with
adenocarcinoma  cells  without  lymph  node  metastases.  The  patient  died  from  haemorrhagic  shock,  due  to
rupture  of  liver  metastases  and  a massive  haemoperitoneum,  within  2 months  of  the initial  presentation.
DISCUSSION:  Primary  gastric  choriocarcinoma  characteristics  resemble  those  of gastric  primary  adeno-
carcinoma.  The  dedifferentiation  theory  is the  most  widely  accepted  theory  to explain  the  pathogenesis
of  PGC.  It is  essential  to  rule  out  other  possible  primary  lesions  such  as  testicular  tumour.  The  optimal
treatment  is not  yet well  established  due  to very  few  reported  cases.
CONCLUSION:  Primary  gastric  choriocarcinoma  is  a  rare  tumour  with  an aggressive  behaviour  and  very
poor prognosis.
©  2015  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Choriocarcinoma is a rapidly growing, widely metastatic and
-HCG (human chorionic gonadotropin)-producing tumour of tro-
phoblastic cells. Most cases arise in the uterus following gestational
events (e.g. normal or ectopic pregnancy or abortion). It can also be
gonadal (ovary and testis) or extragonadal (e.g. lung, gastrointesti-
nal tract, mediastinum or retroperitoneum) in origin [1–5].
First described by Davidsohn in 1905, primary gastric chorio-
carcinoma (PGC) is extremely rare, accounting for approximately
0.08% of all gastric cancers [6,7]. Most PGCs possess an adenocar-
cinoma component of variable magnitude and pure PGC is rare.
Clinical presentation is similar to gastric adenocarcinoma, however
it is more frequently a cause of gastrointestinal bleeding given its
striking vascularity [8]. Deﬁnitive diagnosis by endoscopic biopsy
is rare (8%) and most such cases are diagnosed after surgery [1,6].
The authors report a case of PGC admixed with an adenocarci-
noma component in a male patient.
2. Presentation of case
A 69-year-old white man  presented to the emergency depart-
ment with chief complaints of chest pain, nausea, sweating and
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shortness of breath for a couple of hours’ duration. His past medi-
cal history was signiﬁcant for coronary artery disease. He had had a
previous myocardial infarction and had been submitted to coronary
stent placement. His medication included two antiplatelet drugs
(aspirin and clopidogrel).
Physical examination was  signiﬁcant only for pale skin. The
remainder was unremarkable. Laboratory values on admission
showed severe anaemia (haemoglobin of 3.9 g/dL and haematocrit
of 14.1%) and normal platelet count. The serum albumin levels,
liver function tests, chemistry panels and cardiac markers were also
normal. A 12-lead electrocardiogram revealed no acute ﬁndings.
An upper gastrointestinal endoscopy disclosed a 5 cm-diameter
exophytic ulcer with necrotic areas and stigmata from recent bleed-
ing on the cardia and proximal lesser curvature. A histopathologic
examination of biopsy tissues (7 fragments) revealed carcinoma
cells with highly pleomorphic nuclei and atypical mitotic ﬁgures.
An immunohistochemical study showed strong positivity to pan-
cytokeratin AE1/AE3 and CAM 5.2.
A computed tomography (CT) scan of the pelvis and abdomen
visualized a gastric mass with deep central ulceration, arising from
the gastric fundus and extending to the cardia and proximal lesser
curvature. There were two suspicious microscopic lesions on the
liver. No lymph node metastasis or testicular abnormalities were
observed. A chest X-ray was  normal. A gastrointestinal X-ray exam-
ination demonstrated an ulcerated lesion with a distinct elevation
occupying the cardia, the anterior aspect of the proximal lesser cur-
vature and the fundus. Tumour markers (CEA, CA 19.9, CA 125)
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Fig. 1. H&E 100×—with gastric choriocarcinoma, there is a tendency for the chori-
ocarcinomatous component to metastasize via blood vessels. Numerous images of
vascular invasion were detected.
Fig. 2. H&E 40×—histology revealed a highly invasive malignant neoplasia with
choriocarcinomatous differentiation, including cytotrophoblastic and syncytiotro-
phoblastic elements. Bizarre large nuclei were abundant. Large areas of tumour
necrosis were also seen.
and 2 microglobulin protein were within normal limits. Serum
-HCG levels were extremely high (2140 mIU/ml—normal range
<0.5 mIU/ml).
The patient was given multiple blood transfusions and
ultimately underwent radical total gastrectomy with D2 lym-
phadenectomy and Roux-en-Y reconstruction. Exploration of the
abdomen at the time of surgery revealed no evidence of macro-
scopic disease in the liver, peritoneum or retroperitoneum. The
resected specimen contained a 7 cm exophytic tumour with cen-
tral ulceration and areas of vascular congestion. Histologically, the
neoplasm was strongly vascularized with extensive necrotic areas
(Fig. 1) and had two distinct components. The main component
(95%) consisted of highly pleomorphic cells with cytotrophoblas-
tic and syncytiotrophoblastic differentiation, strongly suggestive of
gastric choriocarcinoma (Fig. 2). The remaining 5% of the tumour
was a moderately differentiated invasive adenocarcinoma (Fig. 3).
Strong immunoreactivity for -HCG was seen in the trophoblas-
tic cells and the entire tumour was cytokeratin 7 positive (Fig. 4).
The tumour had extended to subserosa (T2b) and no metastases
were found in the 14 perigastric lymph nodes resected (N0). Both
resected margins were free of tumour. Extensive vascular and per-
ineural invasion was present.
Fig. 3. H&E 100×—a small superﬁcial area of moderately differentiated adenocar-
cinoma was also identiﬁed, comprising approximately 5% of the tumour.
Based on pathological ﬁndings and in the absence of a testicular
mass, the patient was diagnosed with PGC with an adenocarcinoma
component. The post-operative course was uneventful and he was
discharged 9 days after surgery.
He returned to the emergency department with complaints
of sudden right upper quadrant abdominal pain, vomiting and
severe anaemia (3.7 g/dL), 12 days after discharge. A repeated CT
scan of the abdomen revealed multiple liver metastases in the
right and left lobes. Some lesions had ruptured causing a mas-
sive haemoperitoneum, conﬁrmed by paracentesis (Fig. 5). Despite
efforts to resuscitate the patient, this was  a terminal event. The
patient died from haemorrhagic shock, 40 days after initial presen-
tation.
3. Discussion
Primary gastric choriocarcinoma is a rare and highly aggressive
tumour characterized by the presence of a double cell popula-
tion and early metastases, especially in the liver, lung and regional
lymph nodes [7,9]. Several theories have been proposed to explain
the pathogenesis of PGC. The most widely accepted is the dediffer-
entiation theory. First proposed by Pick in 1926 [10], this theory
showed a dedifferentiation of the malignant gastric adenocarci-
noma cells to the level of the embryonal ectoderm, retaining the
ability to form trophoblasts [11,12]. Pure choriocarcinoma would
arise through overgrowth and elimination of the original ade-
nocarcinoma [9]. Supporting this theory is the ﬁnding that PGC
characteristics resemble those of gastric primary adenocarcinoma:
mean age of onset, male-female ratio, tumour location and similar
geographic distribution [9,13]. Additionally, 71% of PGCs are associ-
ated with poorly differentiated adenocarcinoma and less than 25%
are pure choriocarcinoma [8,14]. According to Noguchi et al., 70%
of PGCs have an adenocarcinoma component and most patients
have early metastases [6]. Liu et al. reported that PGC genetically
possesses characteristics of both adenocarcinoma and gestational
choriocarcinoma [15]. This tumour has haematogenous dissemi-
nation as opposed to lymphatic spread of gastric adenocarcinoma
[12].
Despite the generalized acceptance of the dedifferentiation the-
ory, one question remains: what is the role of HCG-producing cells,
normally present in the gastric mucosa? Yakeishi et al. demon-
strated the existence of HCG-producing cells in choriocarcinomas
as well as in adenocarcinomas and in the normal gastric mucosa,
in different proportions. Normal gastric cells with the ability to
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Fig. 4. Immunohistochemistry 100×—the immunohistochemical study with antibodies for citokeratin 7 and -HCG showed positive staining, conﬁrming the choriocarcino-
matous  nature of the tumour.
Fig. 5. Contrast-enhanced CT scan of abdomen taken in arterial and portal venous phases showed hipervascular liver metastases with signs of active bleeding from subcapsular
lesions,  causing hemoperitoneum.
produce HCG directly may  develop into a de novo PGG, without
a preceding adenocarcinoma (e.g. some pure forms of PGC) [9].
Histologically, there is a combination of malignant cytotro-
phoblasts and syncytiotrophoblasts, in most cases admixed with
adenocarcinoma cells [8]. Trophoblastic cells stain positive for -
HCG in immunohistochemistry and most cases are accompanied
by elevated serum -HCG. Serum -HCG has no prognostic signif-
icance but may  be useful for evaluating response to treatment and
tumour recurrence [8,12].
Differential diagnosis of PGC is a metastatic trophoblastic
tumour from other sites, which are more frequent than PGC [12]. It
is crucial to rule out other possible primary lesions and to conﬁrm
that -HCG becomes normal after tumour resection. The treatment
of choice has not been established. Current treatment includes gas-
trectomy with lymphadenectomy, since most PGCs are known to
have an adenocarcinoma component, combined with chemother-
apy [14]. There is no established regimen of chemotherapy for PGC
[1].
The prognosis is considerably worse than that of gastric adeno-
carcinoma. Most patients have early metastases in the lung, liver
and regional lymph nodes [8,9]. The mean survival time is less than
2 months [14]. Most patients die of hepatic failure due to liver
metastases and bleeding from the primary/metastatic tumour [6].
4. Conclusion
Primary gastric choriocarcinoma is a rare tumour with an
aggressive behaviour [1,4]. The optimal treatment has not yet been
established due to very few reported cases and patients have a very
poor prognosis [11].
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